GlassScriptPhysician profile
Mohinder P Gupta
NPI 1659337285
$22,123.70
in general payments reported to CMS, 2019-2025
36 companies · $773 in 2025
The $773 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,640 · 2020: $2,526 · 2021: $4,714 · 2022: $5,301 · 2023: $3,090 · 2024: $1,080 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,942.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,752.66 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,440.96 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $2,174.13 | 2019-2024 | Xarelto |
| Medtronic, INC. | $2,020.68 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan, Micra |
| Boston Scientific Corporation | $1,934.97 | 2019-2025 | Accolade Sr, Watchman Access System, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $1,419.76 | 2019-2023 | Farxiga |
| Pfizer INC. | $1,343.99 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $949.42 | 2019-2023 | Verquvo |
| Abbott Laboratories | $922.57 | 2020-2023 | Freestyle Libre 3, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $881.38 | 2019-2025 | |
| Amgen INC. | $685.39 | 2019-2023 | Repatha |
| Medtronic Vascular, INC. | $673.39 | 2019-2020 | |
| Esperion Therapeutics, INC. | $582.14 | 2021-2025 | Nexletol |
| Edwards Lifesciences Corporation | $563.01 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $464.27 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $365.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $271.62 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $229.80 | 2019-2023 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $186.64 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $160.20 | 2019-2021 | |
| Cequr Corporation | $140.38 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $129.26 | 2023-2024 | Inpefa |
| Dexcom, INC. | $125.00 | 2022 | |
| Glaxosmithkline, LLC. | $124.76 | 2021 | |
| Intuity Medical INC | $123.62 | 2022 | |
| Gilead Sciences, INC. | $83.63 | 2019 | |
| Alnylam Pharmaceuticals INC. | $76.77 | 2022-2023 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $73.13 | 2019-2023 | Evkeeza, Praluent |
| Kowa Pharmaceuticals America, INC. | $60.94 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $43.25 | 2022 | |
| Heartflow, INC. | $24.84 | 2023 | Ffrct |
| Abiomed | $23.08 | 2022 | |
| Biotronik INC. | $22.32 | 2020 | |
| Baxter Healthcare | $19.12 | 2023 | Hillrom - Connex Spot Monitor |
| Akcea Therapeutics, INC. | $16.88 | 2019 | |
| Azurity Pharmaceuticals, INC. | $14.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohinder Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.